| Tamsulosin treatment increases clinical success rate of single extracorporeal shock wave lithotripsy of renal stones GL Gravina, AM Costa, P Ronchi, GP Galatioto, A Angelucci, D Castellani, ... Urology 66 (1), 24-28, 2005 | 265 | 2005 |
| An overview of the effect of linoleic and conjugated‐linoleic acids on the growth of several human tumor cell lines M Maggiora, M Bologna, MP Cerù, L Possati, A Angelucci, A Cimini, ... International journal of cancer 112 (6), 909-919, 2004 | 162 | 2004 |
| Inhibition of protein kinase c-Src reduces the incidence of breast cancer metastases and increases survival in mice: implications for therapy N Rucci, I Recchia, A Angelucci, M Alamanou, A Del Fattore, D Fortunati, ... Journal of Pharmacology and Experimental Therapeutics 318 (1), 161-172, 2006 | 157 | 2006 |
| Kinase-dependent and-independent roles of EphA2 in the regulation of prostate cancer invasion and metastasis ML Taddei, M Parri, A Angelucci, B Onnis, F Bianchini, E Giannoni, ... The American journal of pathology 174 (4), 1492-1503, 2009 | 134 | 2009 |
| Osteoblast conditioned media contain TGF‐β1 and modulate the migration of prostate tumor cells and their interactions with extracellular matrix components C Festuccia, M Bologna, GL Gravina, F Guerra, A Angelucci, I Villanova, ... International journal of cancer 81 (3), 395-403, 1999 | 124 | 1999 |
| Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression P Sanità, M Capulli, A Teti, GP Galatioto, C Vicentini, P Chiarugi, ... BMC cancer 14, 1-14, 2014 | 116 | 2014 |
| Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice A Angelucci, GL Gravina, N Rucci, D Millimaggi, C Festuccia, P Muzi, ... Endocrine-related cancer 13 (1), 197-210, 2006 | 113 | 2006 |
| Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines A Angelucci, S D'Ascenzo, C Festuccia, GL Gravina, M Bologna, V Dolo, ... Clinical & experimental metastasis 18, 163-170, 2000 | 109 | 2000 |
| Identification of a Novel Pyrazolo[3,4-d]pyrimidine Able To Inhibit Cell Proliferation of a Human Osteogenic Sarcoma in Vitro and in a Xenograft Model in Mice F Manetti, A Santucci, GA Locatelli, G Maga, A Spreafico, T Serchi, ... Journal of medicinal chemistry 50 (23), 5579-5588, 2007 | 103 | 2007 |
| Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary cultures C Vicentini, C Festuccia, GL Gravina, A Angelucci, A Marronaro, ... Journal of cancer research and clinical oncology 129, 165-174, 2003 | 99 | 2003 |
| Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity C Festuccia, A Angelucci, GL Gravina, L Biordi, D Millimaggi, P Muzi, ... Thrombosis and haemostasis 93 (05), 964-975, 2005 | 96 | 2005 |
| Src family kinases as therapeutic targets in advanced solid tumors: what we have learned so far S Martellucci, L Clementi, S Sabetta, V Mattei, L Botta, A Angelucci Cancers 12 (6), 1448, 2020 | 94 | 2020 |
| Receptor activator of NF-κB ligand enhances breast cancer–induced osteolytic lesions through upregulation of extracellular matrix metalloproteinase inducer/CD147 N Rucci, D Millimaggi, M Mari, A Del Fattore, M Bologna, A Teti, ... Cancer research 70 (15), 6150-6160, 2010 | 91 | 2010 |
| Bone-targeted doxorubicin-loaded nanoparticles as a tool for the treatment of skeletal metastases M Salerno, E Cenni, C Fotia, S Avnet, D Granchi, F Castelli, D Micieli, ... Current cancer drug targets 10 (7), 649-659, 2010 | 90 | 2010 |
| Osteoblast‐derived TGF‐β1 modulates matrix degrading protease expression and activity in prostate cancer cells C Festuccia, A Angelucci, GL Gravina, I Villanova, A Teti, A Abini, ... International journal of cancer 85 (3), 407-415, 2000 | 89 | 2000 |
| Pyrazolo [3, 4-d] pyrimidines c-Src inhibitors reduce epidermal growth factor-induced migration in prostate cancer cells A Angelucci, S Schenone, GL Gravina, P Muzi, C Festuccia, C Vicentini, ... European Journal of Cancer 42 (16), 2838-2845, 2006 | 88 | 2006 |
| Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases F Margheri, S D'alessio, S Serrati, M Pucci, F Annunziato, L Cosmi, ... Gene Therapy 12 (8), 702-714, 2005 | 88 | 2005 |
| EphA2 induces metastatic growth regulating amoeboid motility and clonogenic potential in prostate carcinoma cells ML Taddei, M Parri, A Angelucci, F Bianchini, C Marconi, E Giannoni, ... Molecular cancer research 9 (2), 149-160, 2011 | 87 | 2011 |
| Osteopontin enhances the cell proliferation induced by the epidermal growth factor in human prostate cancer cells A Angelucci, C Festuccia, GL Gravina, P Muzi, L Bonghi, C Vicentini, ... The Prostate 59 (2), 157-166, 2004 | 86 | 2004 |
| Antiproliferative and proapoptotic activities of new pyrazolo[3,4‐d]pyrimidine derivative Src kinase inhibitors in human osteosarcoma cells A Spreafico, S Schenone, T Serchi, M Orlandini, A Angelucci, D Magrini, ... The FASEB Journal 22 (5), 1560-1571, 2008 | 82 | 2008 |
Claudio FestucciaUniversità di L'AquilaVerified email at univaq.it
